Clinical presentation and outcome of children with central diabetes insipidus associated with a self-limited or transient pituitary stalk thickening, diagnosed as infundibuloneurohypophysitis by Schaefers, J et al.
Clinical Endocrinology. 2017;87:171–176. wileyonlinelibrary.com/journal/cen | 171
Received:16December2016  |  Revised:19April2017  |  Accepted:23April2017
DOI:10.1111/cen.13362
O R I G I N A L  A R T I C L E
Clinical presentation and outcome of children with 
central diabetes insipidus associated with a self- limited 
or transient pituitary stalk thickening, diagnosed as 
infundibuloneurohypophysitis
J. Schaefers1  | M. Cools2 | K. De Waele2 | I. Gies3 | V. Beauloye4 | P. Lysy4 |  



























































a normal (or sometimes decreasing) anterior pituitary size at serial
imaging, thediagnosis of (lymphocytic or autoimmune) infundibulo-
neurohypophysitis (INH)hasbeenmademorefrequentlyduringthe
lastyears,6-9even in theabsenceofcirculatingauto-antibodiesora
histological confirmation of lymphocytic infiltration. The diagnosis
ofINHisfrequentlymadebyexclusionandremainsinthefirstyears
of presentation uncertain, even with histological confirmation.10,11 
Furthermore, pituitary stalk biopsies, especially in children, are in
general reserved for thosepatientswithprogressiveor severe stalk
thickening,visualcomplaintsand/orevolvingpituitaryhormonaldefi-
cits.4,12-15Beside thediagnosticuncertainty, there isalsodiscussion
ontheneedofcorticoidtreatmentorotherimmuno-modulatingtreat-
mentsinchildren.8,16-18
To date, there have been only two paediatric cohort studies




disease,we initiated a retrospective studyon the clinical presen-
tation, theevolutionofstalk thicknessatserialMRIandeventual
associatedendocrinedeficitsinchildrenwithCDIandaself-limited





Cases were identified from the paediatric endocrine databases of
four participatingBelgian pediatric university hospitals (UZBrussel,
Brussels;UZGent,Ghent,CliniquesUniversitairesSaintLuc,Brussels
andUZLeuven,Leuven).Allpaediatric (age<16years)patientswith



















infundibulum involvement, stalk thickness atwidest diameter, stalk
contrast enhancement at diagnosis and during follow-up, pituitary





andpolyuriawith inappropriatediluteurine in thepresenceofhigh
plasma osmolality, either spontaneously or afterwater deprivation.
MRIwasperformedaccordingtolocalprotocols,andinallcases,an
entirebrain survey, includinggadoliniumenhancementcontrasten-








































All patients had an evaluation of the anterior pituitary function by
basal hormonal analysis at diagnosis.One patient had an asympto-
matic central hypothyroidism at presentation. A low GH response
after insulintolerancetestwasnoticedinoneofthethreepatients,
whohadan insulin tolerance test in theircomplementaryhormonal
work-up,butthispatienthadhadnormalgrowthinprecedingyears













antithyroid microsomal antibodies (TPO) and antigrowth hormone
antibodies.
3.5 | MRI findings



















was expected, given an initial increase in ST.None of the patients








of the thickening of the stalk before a spontaneous regression oc-
curred.Sixpatientshada completenormalizationof theST.ST re-
gression was documented after a mean follow-up of 17months
(range3-48months).Thepatientwhoreceived8weeksoforalgluco-
corticoidshadadocumentedSTregressionafter3months.Thetwo
patientswithapersisting stalk thickeninghada follow-upof3and






































This so-called stalkitis or inflammatoryST is suspected tobeof





of our cohort, a screening for circulating auto-antibodies was per-
formed,beingpositiveinonepatient.Vasopressin-cellauto-antibodies
andother auto-antibodies are frequently, butnot alwayspresent in









Clinically, our cohort of young patients,who presented allwith
CDI, had no clinical symptoms of anterior lobe dysfunction or hy-




reported previously in series of adult and paediatric patients with













duringthefirstyear, incaseof initial isolatedstalk involvementand
have frequently skull involvement.11All ofourpatientshad at least
3-monthlyclinicalevaluationsand6-monthlyMRIevaluationsduring
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A limitation of our study is the retrospective study design. All
childrenunderwentdifferenthormonal andbiological testingatdif-
ferentmoments in thefollow-up,and inparticular, theautoimmune
parameterswereonlytestedinalimitedgroupofchildren.Thedegree
ofpituitarydysfunctionmight thusbeunderestimated.Antipituitary
antibodies were only determined in two patients, and no data on
vasopressin-cell auto-antibodieswere available, because no labora-
tory inBelgiumprovidesthisanalysis.Severalmethodsexist forthe
detection of antipituitary antibodies, with indirect immunofluores-
cence the most commonly available technique. But even with the











is an uncommon condition in paediatrics. INHwas found to occur
inyoungchildren,even from theageof3,withouta femalegender




presenceofotherbrainanomaliesareeventual risk factors for INH.
Prospectivecollectionofcasesthroughanationalregistryisadvocated
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